The aim of 2.4M€ project CURE-OP is to develop the first commercially available high intensity focused ultrasound (HIFU) platform specifically designed for combinational cancer therapy. We will develop a robotic device that can deliver a broad range of ultrasound regimes (hyperthermia, thermal ablation and cavitation) enabling different types of cancer polytherapy. In the scope of this project’s timeframe, the HIFU device will be used in combination with a radiotherapy (RT) machine and tested clinically. Mediri will develop vital software components for image registration and tracking which will be integrated into Theraclion’s therapy unit.
Surgeons and oncologists have been showing a keen interest in using HIFU to treat cancer, especially in combination with existing treatments. HIFU is a non-ionizing radiation, which can enhance RT treatments, thus increasing the safety profile and efficacy with reduced ionizing radiation and lower costs of the overall treatment. It will be possible to explore other combinational therapies such as local drug delivery and immunotherapy with malignant tumour ablation.